Genetic Signatures Ltd (GSS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.008x

Based on the latest financial reports, Genetic Signatures Ltd (GSS) has a cash flow conversion efficiency ratio of -0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-349.00K ≈ $-246.94K USD) by net assets (AU$44.09 Million ≈ $31.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Genetic Signatures Ltd (GSS) defensive interval to measure how many days the company can operate on defensive assets alone.

Genetic Signatures Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Genetic Signatures Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Genetic Signatures Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genetic Signatures Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
DCI O.N. F:DCIK	N/A
Art Nirman Limited NSE:ARTNIRMAN	0.004x
RomReal Limited OL:ROM	0.185x
Inventure Growth & Securities Limited NSE:INVENTURE	0.008x
First Lithium Ltd AU:FL1	-0.118x
Gratifii Ltd AU:GTI	0.129x
ABX Group Ltd AU:ABX	-0.145x
Motio Ltd AU:MXO	0.190x

Annual Cash Flow Conversion Efficiency for Genetic Signatures Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Genetic Signatures Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Genetic Signatures Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$50.09 Million ≈ $35.44 Million	AU$-12.29 Million ≈ $-8.70 Million	-0.245x	-48.12%
2024-06-30	AU$61.10 Million ≈ $43.23 Million	AU$-10.12 Million ≈ $-7.16 Million	-0.166x	+42.92%
2023-06-30	AU$42.91 Million ≈ $30.36 Million	AU$-12.45 Million ≈ $-8.81 Million	-0.290x	-262.15%
2022-06-30	AU$54.80 Million ≈ $38.78 Million	AU$9.81 Million ≈ $6.94 Million	0.179x	+110.46%
2021-06-30	AU$49.34 Million ≈ $34.91 Million	AU$4.20 Million ≈ $2.97 Million	0.085x	+141.13%
2020-06-30	AU$45.93 Million ≈ $32.50 Million	AU$-9.49 Million ≈ $-6.72 Million	-0.207x	+3.71%
2019-06-30	AU$10.57 Million ≈ $7.48 Million	AU$-2.27 Million ≈ $-1.61 Million	-0.215x	+22.12%
2018-06-30	AU$13.40 Million ≈ $9.48 Million	AU$-3.69 Million ≈ $-2.61 Million	-0.276x	-76.69%
2017-06-30	AU$16.49 Million ≈ $11.66 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.156x	+71.62%
2016-06-30	AU$4.68 Million ≈ $3.31 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.550x	-38.78%
2015-06-30	AU$7.06 Million ≈ $4.99 Million	AU$-2.80 Million ≈ $-1.98 Million	-0.396x	-372.97%
2014-06-30	AU$16.18 Million ≈ $11.45 Million	AU$-1.35 Million ≈ $-958.56K	-0.084x	-123.40%
2013-06-30	AU$-3.32 Million ≈ $-2.35 Million	AU$-1.19 Million ≈ $-839.81K	0.358x	--

About Genetic Signatures Ltd

AU:GSS Australia Diagnostics & Research

Market Cap

$10.77 Million

AU$15.22 Million AUD

Market Cap Rank

#26867 Global

#1294 in Australia

Share Price

AU$0.07

Change (1 day)

-4.29%

52-Week Range

AU$0.07 - AU$0.42

All Time High

AU$2.75